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Protocol
AbstrACt
Introduction Sleep is a state of quiescence that 
facilitates the significant restorative processes that 
enhance individuals’ physiological and psychological 
well-being. Patients admitted to the intensive care unit 
(ICU) experience substantial sleep disturbance. Despite the 
biological importance of sleep, sleep monitoring does not 
form part of standard clinical care for critically ill patients. 
There exists an unmet need to assess the feasibility and 
accuracy of a range of sleep assessment techniques that 
have the potential to allow widespread implementation of 
sleep monitoring in the ICU.
Key measures The coprimary outcome measures of 
this study are to: determine the accuracy and feasibility 
of motion accelerometer monitoring (ie, actigraphy) 
and subjective assessments of sleep (nursing-based 
observations and patient self-reports) to the gold standard 
of sleep monitoring (ie, polysomnography) in evaluating 
sleep continuity and disturbance. The secondary outcome 
measures of the study will include: (1) the association 
between sleep disturbance and environmental factors (eg, 
noise, light and clinical interactions) and (2) to describe the 
sleep architecture of intensive care patients.
Methods and analysis A prospective, single centre 
observational design with a within subjects’ assessment 
of sleep monitoring techniques. The sample will comprise 
80 adults (aged 18 years or more) inclusive of ventilated 
and non-ventilated patients, admitted to a tertiary ICU with 
a Richmond Agitation-Sedation Scale score between +2 
(agitated) and −3 (moderate sedation) and an anticipated 
length of stay >24 hours. Patients’ sleep quality, total 
sleep time and sleep fragmentations will be continuously 
monitored for 24 hours using polysomnography 
and actigraphy. Behavioural assessments (nursing 
observations) and patients’ self-reports of sleep quality will 
be assessed during the 24-hour period using the Richards-
Campbell Sleep Questionnaire, subjective sleepiness 
evaluated via the Karolinska Sleepiness Scale, along 
with a prehospital discharge survey regarding patients’ 
perception of sleep quality and disturbing factors using the 
Little Sleep Questionnaire will be undertaken. Associations 
between sleep disturbance, noise and light levels, and the 
frequency of clinical interactions will also be investigated. 
Sound and luminance levels will be recorded at 1 s epochs 
via Extech SDL600 and SDL400 monitoring devices. 
Clinical interactions will be logged via the electronic 
patient record system Metavision which documents patient 
monitoring and clinical care.
Ethics and dissemination The relevant institutions have 
approved the study protocol and consent procedures. The 
findings of the study will contribute to the understanding 
of sleep disturbance, and the ability to implement sleep 
monitoring methods within ICUs. Understanding the 
contribution of a clinical environment on sleep disturbance 
may provide insight into the need to address clinical 
environmental issues that may positively influence patient 
outcomes, and could dispel notions that the environment 
is a primary factor in sleep disturbance. The research 
findings will be disseminated via presentations at national 
and international conferences, proceedings and published 
articles in peer-reviewed journals.
trial registration number ACTRN12615000945527; Pre-
results.
IntroduCtIon 
Sleep is widely acknowledged to be important 
for optimal physical and psychological perfor-
mance and well-being.1–3 Patients cared for in 
intensive care unit (ICU) experience substan-
tial sleep disturbance,4–6 for which the aeti-
ology is likely multifactorial. Intrinsic factors 
associated with critical illnesses (eg, disrup-
tion of the circadian rhythm) and extrinsic 
environmental factors (eg, noise, light and 
clinical interactions) contribute to poor sleep 
among this patient cohort.7–10 
Previous research has shown that the sleep 
architecture of patients admitted to the ICU 
is characterised by significant fragmenta-
tion and lack of deep sleep, with their sleep 
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architecture predominantly comprising non-rapid eye 
movement (ie, stages 1 and 2 of the sleep cycle). This may 
limit the restorative functions of sleep and exacerbate 
deranged circadian rhythms.1 11 12 Previous studies have 
described the somatic, cognitive and physiological effects 
of sleep disturbance.13–16 Neurocognitive disturbances 
have been reported to persist postdischarge and are asso-
ciated with a permanent decline in working memory.17–20
For critically ill patients, alteration to circadian patterns 
is associated with a decrease in overall well-being and 
prolonged recovery from critical illness.21–23 Further, 
poor sleep is considered a major stressor for patients, 
which is acknowledged by family members and clinical 
staff,24 25 and is associated with an increased incidence of 
delirium.3 26 Preventing and treating sleep disturbance in 
the ICU may reduce morbidity and mortality. However, 
understanding and monitoring the sleep patterns of 
ICU patients require the identification of accurate and 
feasible sleep monitoring techniques suitable for wide-
spread implementation.
sleep monitoring
Polysomnography (PSG) is the gold standard of sleep 
monitoring and can provide objective information of the 
sleep architecture of patients both during ICU admission 
and subsequent to discharge.1 8 11 12 27 However, its appli-
cation to the ICU environments is limited due to the costs 
associated with monitoring, the technical skills required 
to interpret the results and the uncertainty in describing 
common PSG patterns observed in critically ill patients 
according to standard physiological sleep patterns.28–31
In contrast, the implementation of subjective 
behavioural assessment performed by clinical staff to 
assess patients sleep is an inexpensive process. However, 
few of the commonly employed sleep questionnaires 
have been validated for use within the ICU population, 
and there are concerns regarding the clinical accuracy 
of subjective assessments compared with biophysiolog-
ical-based monitoring.32While, the implementation of 
questionnaires is inherently less complex, their clinical 
utility is questionable given that 50% of ICU patients 
do not have the mental acumen required to complete 
such questionnaires.33 Despite these issues, research 
conducted by Litton et al indicated that nursing staff 
are confident in documenting the differences between 
sleep and sedation.34 However, research also suggests 
nurses overestimate patients’ total sleep time regardless 
of the method employed to document sleep (real time 
or morning after documentation), and has been found 
to correlate poorly with patients’ perceptions of their 
sleep.4 12 29 35–37 For example, research undertaken by 
Kamdar et al14 investigating the nurse–patient reliability 
of the Richards-Campbell Sleep Questionnaire (RCSQ) 
found the nurses significantly overestimated sleep depth 
and sleep quality. Similar findings have been reported in 
studies which required five minutely nursing documenta-
tion of patients sleep status, whereby nurses significantly 
overestimated sleep compared with PSG.38 In contrast, 
Edwards and Schuring39 who compared 15 minutely 
nursing-based assessment of patient’s sleep–wake status 
compared with PSG identified nursing assessment as 
being correct 82% of the time. However, the authors 
noted issues attributed to missing data and the impact 
of confounding factors such as sedation on the assess-
ment process. A primary limitation of this study was the 
brief documentation period (4 hours), which may not 
adequately reflect the extent of monitoring required 
to evaluate sleep sufficiently. More recently, it has been 
suggested that subjective and objective measures may be 
complementary to inform staff regarding patients sleep 
quality.39 As a result, the evolution of new devices such 
as motion accelerometers may be a valuable adjunct to 
monitoring sleep in the ICU.
Presently, there is an unmet need for an inexpensive 
and accurate method to assess total sleep time and sleep 
fragmentation. Motion accelerometers, such as actig-
raphy (ACTG) are a non-invasive method employed to 
monitor human rest/activity cycles. ACTG represents 
a more feasible sleep monitoring method compared 
with PSG, as it is relatively cheap, easy to implement 
and discontinue and produces easy to interpret results. 
ACTG has been found to have a high level of agreement 
(ie, >90%) with PSG in healthy participants; however, 
limited research has been conducted on the reliability 
and accuracy of ACTG in ICU populations, and the 
research that has been undertaken has yielded conflicting 
results.40–42
Extrinsic disruption to sleep: the clinical environment
The apportionment of the clinical environment to sleep 
disturbance has been reported subjectively by patients, and 
in studies using objective assessments such as noise (dB-A 
and dB-C) and light (lux) monitoring. However, the rela-
tive contributions of the specific elements of the clinical 
environment on sleep disturbance are uncertain. A review 
undertaken by Xie et al reported that the effect of noise on 
sleep contributed to between 17% and 57% of arousal and 
awakenings.43 In contrast, Gabor et al8 and Freedman et al4 
reported that only 11%–24% of sleep arousal was attribut-
able to noise events, suggesting that these results may reflect 
an adaptive response to clinical environments.
The ability of the patient to adapt to the clinical envi-
ronment has been questioned, and emerging research 
suggests that noise variability may be a significant factor 
for sleep disturbance rather than the ambient noise 
levels. Delaney et al44 reported noise variability in the ICU 
environment to range between 9.9 and 44 dB(A) over 
5 min intervals, with noise sources >70 dB(A) occurring 
10 times per hour. Secondary to the unpredictability of 
the environment, it is unlikely that patients could become 
accustomed to the diverse and rapid noise variations. 
Efforts to implement behavioural-based interventions to 
reduce noise levels have demonstrated limited success, 
with studies reporting a reduction in the subjective 
perception of noise levels.44 45 Although, these have not 
translated to a measurable reduction in noise levels, or an 
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ability to sustain the reported reductions.45 Subsequently, 
there has been an emergence of research investigating 
environmental masking, such as the effects of earplugs 
and eye masks as methods to reduce patients’ exposure to 
noise and light.46 47
Extrinsic disruptions in the form of clinical interactions 
are frequent among this patient cohort. Early observa-
tional studies48 49 reported that patients are disturbed 
between 1 and 14 times per hour, with the longest 
period of uninterrupted sleep being 43 min. In contrast, 
studies conducted by Tamburri et al50 and Celik et al51 
reported much higher patient to staff interactions, with 
both studies reporting between 40 and 60 interactions 
per night, and as high as 20–60 interactions per hour 
in mechanically ventilated patients. This has significant 
implications on patients’ ability to sleep, with reports 
indicating that 50% of ICU patients recall being woken 
two to five times throughout the night, and once woken 
up expressed difficulty in falling asleep again.1 10 52 The 
frequency of clinical interaction can adversely impact on 
total sleep time and contributes to sleep disturbance, and 
in turn leads to poor quality of sleep. However, minimal 
studies have been conducted that concurrently monitors 
the biophysiological component of sleep to identify if 
some or all interaction contributes to sleep disturbance.
Intrinsic disruption to sleep: critical illness
Intrinsic factors associated with critical illnesses (rather 
than clinical environments) may be the leading causes 
of sleep disturbance.7 53 54 The effects of extrinsic factors 
compared with intrinsic factors on sleep quality have not 
yet been fully elucidated; however, emerging neuroimmu-
nological research suggests that sleep disturbance may have 
an adverse impact on immunological responses. In partic-
ular, the suppression of the adaptive immune response and 
the increased activity of proinflammatory cytokines exacer-
bating sleep fragmentation.55 56
Understanding the dynamics between extrinsic and 
intrinsic factors and their effect on sleep is complex, 
which is further compounded by a lack of congruence 
between patients’ subjective reports and physiological 
measurements of sleep. Subjective studies indicate that 
ICU survivors perceived light exposure to be minimally 
disruptive to their ability to sleep,57 although it appears to 
have a detrimental effects on circadian patterns. Melatonin 
plays an important role in regulating the sleep wake cycle, 
with research indicating the ICU patients demonstrate a 
suppression in endogenous melatonin secretions.58–60 The 
role that melatonin plays in regulating circadian patterns 
continues to be of interest to researchers, with studies inves-
tigating optimal administration patterns and assessment of 
its biophysiological impact on sleep architecture.
study AIMs
The aims of this study are to:
1. Determine the accuracy and feasibility of motion ac-
celerometer monitoring (ie, ACTG) and subjective 
assessments of sleep (nursing-based observations and 
patient self-reports RCSQ) to the gold standard of 
sleep monitoring (ie, PSG) in evaluating sleep conti-
nuity and disturbance.
2. Identify the association between sleep disturbance en-
vironmental factors (eg, noise, light and clinical inter-
actions).
3. Describe the sleep architecture of intensive care 
patients.
MEthods And AnAlysIs
study design and setting
The observational study will have a within-subject 
design. Specifically, concurrent sleep monitoring will be 
performed using ACTG, PSG, nurses’ subjective assess-
ments documented hourly and questionnaires (RCSQ, 
Karolinska Sleepiness Scale (KSS) and the Little Sleep 
Questionnaire (LSQ)) completed by patients. Further, 
the effects of the clinical environment (ie, noise, light 
and clinical interactions) as factors affecting sleep distur-
bance will be investigated. The information obtained 
from the environmental monitoring will be compared 
with the arousal and wakeful event findings recorded by 
the PSG to ascertain their effects on patients’ sleep.
The study site is a 31-bed tertiary referral ICU at an 
Australian teaching hospital that provides combined 
ICU and high dependency care. The unit admits approx-
imately 2000 patients per year, including medical and 
surgical, admissions for trauma, neurosurgical and 
cardiothoracic care. The unit is located on the second 
floor of the hospital and has an open plan design with 
large fixed casement windows, two open plan nursing 
stations, shared bed spaces separated by disposable poly-
propylene non-woven curtains, partially enclosed walls 
and four dedicated isolation bays.
Participants
Adults (aged 18 years and above), requiring ICU level 
care beyond the next calendar day, who score between +2 
(ie, agitated) and −3 (ie, moderate sedation) on the 
Richmond Agitation-Sedation Scale (RASS) will be 
eligible for inclusion in the study. Sleep monitoring 
will be commenced between 13:00 and 16:00 hours and 
conducted over a single 24-hour period, as patients’ sleep 
frequently traverses both day and night. The exclusion 
criteria are summarised in box 1.
demographics and clinical data
The following variables will be collected: gender age, 
Acute Physiology and Chronic Health Evaluation 
(APACHE II) score, and APACHE II diagnostic classifi-
cation, continuous renal replacement therapy, type of 
respiratory support, length of ICU admission when sleep 
monitoring was commenced, the use of eye masks or 
ear plugs, the presence or absence of physical restraints, 
delirium score (confusion assessment method: ICU), 
ICU length of stay (LOS), hospital LOS and mortality 
(alive/deceased in ICU or hospital). Further, the use of 
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analgosedation, antipsychotic and hypnotic medications, 
administration of melatonin, inotropes and vasopressors 
will be documented to assess the heterogeneity of the 
sample and enable the measurement of predictive factors.
sample size and power
The sample size for the study was based on Cohen’s61 
power primer, with an alpha value of 0.05 and a power of 
80%, resulting in a minimum sample size of 67 patients 
to be recruited into the study in order to determine an 
absolute difference (moderate size effect; 0.3) between 
the sleep monitoring methods PSG and ACTG. To 
account for missing data such as incomplete monitoring 
and discharge prior to completion the sample size was 
increased by 20% to a total of 80 participants for the study.
sleep monitoring protocol and interventions
Actigraphy
ACTG will be applied to a patient’s wrist (similar to a 
wristwatch). ACTG is capable of sensing motion with the 
resultant forces of at least 0.01 g, and has a sampling rate 
of 32 Hz. An Actiwatch (by Phillips Respironics) will be 
applied to the wrist of each participant in the study on 
the side that has the least invasive devices (eg, intrave-
nous cannulation, arterial line and sphygmomanometer). 
Recordings will be synchronised with the PSG to deter-
mine the reliability and accuracy of the device. ACTG 
data will be collected at 30 s epochs.
Polysomnography
The Embla PSG (VMedical) ambulatory monitoring 
device will be used to continuously monitor participants’ 
PSG scores for a period of 24 hours. The data obtained 
from the PSG (Embla) will be downloaded to a secure 
digital data card manager so that the information can 
be transferred to a personal computer. A board-cer-
tified sleep scientist (Registered Polysomnographic 
Technologist) experienced in PSG scoring will review 
the PSG data to ensure accuracy and consistency in the 
data analysis. To prevent any undue influence secondary 
to knowledge, ascertainment bias and limit the effect of 
the assessors’ inclinations or attitudes towards the sleep 
measures, the sleep scientist reviewing the PSG data will 
be blinded.62
The international 10–20 electrode placement standards 
for portable PSG monitoring will be used to determine 
the positioning of the PSG electrodes; electroencepha-
logram electrode placement: C4/M1, C3/M2, F4/M1, 
F3/M2, O2/M1 and O1/M2. The electro-occulogram 
(EOG)-L (left) electrode will be positioned 1 cm lateral 
and below the left eye outer canthus, EOG-R (right) elec-
trode 1 cm lateral and above the right eye outer canthus, 
EOG-C electrode positioned in the centre of the fore-
head. The electromyography of the submentalis (EMG), 
EMG+and EMG− electrodes positioned under the chin 
and approximately 3 cm apart.
Subjective behavioural monitoring
Subjective assessment of sleep will be based on the 
Edwards and Schuring’s39 method, with nursing staff 
required to manually record each hour the sleep status 
of the patient: awake, asleep for 15 min or less, asleep for 
15–30 min, asleep for 30–45 min, or has been asleep for 
the hour (60 min). The nursing staff will be blinded to 
the PSG and ACTG data, and will not be able to base their 
assessments on this information. The subjective assess-
ment will be integrated into the computerised electronic 
patient data system of MetaVision (iMDsoft), used in the 
ICU to document patients’ clinical care.34
Patient self-reports
The research team will assess each patients’ competency 
based on: (1) the feedback of clinical staff in relation to 
each patient’s cognitive ability; (2) the patient’s negative 
confusion and assessment method results across three 
subscales (ie, inattention, altered level of consciousness 
and disordered thinking) and (3) whether the patient 
has a RASS between −1 (drowsy, but sustained awakening) 
and +1 (restless, but not agitated) (figure 1). Patients 
deemed competent will be invited to complete the 
RCSQ and the KSS, with assistance from clinical staff if 
required. A follow-up questionnaire: LSQ will be under-
taken within 7 days of the patients identified hospital 
discharge date. Where patients do not meet the compe-
tency-based criteria, patient self-reported sleep quality 
via the RCSQ, KSS and LQS will be omitted (refer to 
figure 1).
The Richards-Campbell Sleep Questionnaire
The RCSQ is a five-item questionnaire designed to eval-
uate ICU patients’ quality of sleep and will be completed 
after each patient’s night recording between 09:00 
and 10:00. The RSCQ has previously been validated 
against PSG and comprises five subscales: (1) sleep 
depth, (2) sleep latency, (3) number of awakenings, 
box 1 Exclusion criteria for study participation
Patients will be excluded from this study if on initial assessment.
 ► Admitted to the intensive care unit primarily for a neurological 
condition.
 ► Treatment intent is palliative and/or not expected to survive for more 
than 24 hours.
 ► Confirmed or suspected drug overdose.
 ► Likely to be administered a neuromuscular blocking agent during 
the 24 hours study period.
 ► Likely to be administered a barbiturate during the 24-hour study 
period.
 ► History of cognitive impairment, for example, Alzheimer’s disease.
 ► Have inadequate English language skills to allow completion of a 
sleep survey.
 ► Have facial or skull injuries that prohibit the placement of the 
polysomnography electrodes.
 ► Have injuries that preclude the placement of actigraphy.
 ► Spinal cord injury.
 ► Have clinically suspected encephalopathies (ie, septic, hepatic or 
uraemic encephalopathies).
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(4) efficiency and (5) sleep quality (α=0.90).63 The RCSQ 
is recorded using a 100 mm visual analogue scale. A mean 
score will be derived from the five subscales to provide an 
overall score reflecting patients’ perceptions of their sleep 
quality. A higher score on the questionnaire indicates a 
better quality of sleep.
Karolinska Sleepiness Scale
The KSS is a self-reported nine-point Likert scale of subjec-
tive drowsiness at the point in time of testing to evaluate if 
this precipitates the patient’s onset of sleep. The KSS has 
been widely used, particularly to describe changes over 
time in study participants, and will be completed on initi-
ation of monitoring, between 21:00 and 22:00 hours and 
the following morning within 2 hours of awakening. A 
KSS score >7 reflects a state of drowsiness under which an 
individual may be susceptible to involuntary microsleep 
behaviours with episodic losses of awareness, followed by 
returns of awareness.64
Little Sleep Questionnaire
The LSQ was modelled on the ICU memory tool and 
developed for the use among ICU patient to explore the 
sleep experiences of patients, secondary to a lack sleep 
questionnaires addressing primary issues experienced 
by ICU patients.65 This questionnaire explores patients’ 
perceived quality and quantity of sleep at home prior 
to ICU admission, during their ICU stay and following 
discharge from the ICU; ICU-related factors contributing 
to poor sleep and possible changes in the ICU that could 
improve sleep. The survey will be excluded in instances 
where the patients’ clinical condition or recovery 
precludes their ability to complete the LSQ. The LSQ 
will be conducted post the participants discharge from 
Figure 1 Flow diagram of the monitoring procedure. ACTG, actigraphy; ICU, intensive care unit; KSS, Karolinska Sleepiness 
Scale; LSQ, Little Sleep Questionnaire; PSG, polysomnography; RCSQ, Richards-Campbell Sleep Questionnaire. 
 o
n
 25 April 2018 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2017-019704 on 21 January 2018. Downloaded from 
6 Delaney LJ, et al. BMJ Open 2018;8:e019704. doi:10.1136/bmjopen-2017-019704
Open Access 
the ICU and within 7 days of the participants’ estimated 
hospital discharge date.
Environmental monitoring protocol
Extech sound meter (SDL600: frequency range 
31.5 Hz–8 kHz, decibel range 30–180 dB) and lux metres 
(Extech SDL460: luminance range of 0–1999 lux, accu-
racy: ±4% +2 disability glare threshold) positioned at a 
height of 155 cm behind the head of patients’ beds will 
be used to monitor noise and light. This positioning of 
the sound meter will allow the noise and light sources to 
which each patient is subjected to be monitored without 
interfering with or disrupting a patient’s clinical care. 
These monitors will log noise and light level data at 
1 s epochs over the 24-hour study period. Noise will be 
recorded on the A-weighted decibel (dB) scale that most 
closely reflects the sound and loudness perceived by the 
human ear. Whereas light levels will be recorded in lux, 
the standard unit of measurement in photometry and 
a measurement that is representative of the intensity of 
light perceived by the human eye.
Clinical interactions with patients will be recorded by 
the inpatient electronic data system, Metavision. This 
system documents patient care, including patients’ vital 
signs, medication administration, titrations and clinical 
activities.
outcome measures and instruments
The primary outcome measure of the study is to deter-
mine the accuracy and feasibility of motion accelerom-
eter monitoring (ie, ACTG) and subjective assessments 
of sleep (nursing-based observations and patient self-re-
ports) compared with the gold standard of sleep moni-
toring (ie, PSG) in evaluating sleep continuity and 
disturbance.
Sleep onset will be defined in accordance with the 
American Academy of Sleep Medicine Manual for Scoring 
Sleep and Associated Events (V2.4) as the first epochs of 
any sleep stage.66 Sleep features such as total sleep time, 
total wake time, wake after sleep onset, arousal index and 
sleep efficiency will be correlated to sleep data derived 
from ACTG. The sensitivity (percentage of ACTG data 
that agreed with sleep determined via PSG), specificity 
(percentage of ACTG data that agreed with awake deter-
mined using PSG) and accuracy (ability to detect both 
sleep and wake compared with PSG=number to sleep 
and wake epochs of PSG scored sleep and wake epochs) 
between PSG and ACTG findings will also be analysed.67 
PSG hypnograms will used to depict sleep and sleep 
stages over time, along with reporting the percentage 
of total sleep time in sleep stages N1, N2, N3 and REM 
sleep.
Atypical sleep patterns are known to occur within the 
ICU patient cohort, which hampers the ability to inter-
pret sleep staging based on traditional criteria. In cases 
where atypical PSG data is identified, these will be anal-
ysed based on Watson et al’s31 revised ICU sleep scoring 
criteria.
Box 2 outlines the secondary outcome measures of the 
study, including the percentage of time that participants 
spend in each of the sleep stages as identified by PSG. 
In addition, to comparisons between the subjective sleep 
assessment conducted by clinical staff and the patient 
participants, and sleep disturbances associated with envi-
ronmental factors will be performed.
statistical methods
The data analyses will involve descriptive and analytic 
statistics, calculated using the Statistical Package for 
Social Science (V.20). Descriptive statistics (ie, means, SD 
and ranges) will be used to describe and summarise the 
demographic and clinical features of the study cohort, 
and the categorical data will be presented in frequency 
tables (n, %). The reasons associated with missing data 
attribute to PSG and ACTG monitoring will be docu-
mented and included in the analysis to explore the clin-
ical application of these monitoring techniques. In the 
instances where data is missing for nursing-based obser-
vations of patient sleep an imputation method of the 
last observation carried forward will be applied.68While, 
missing data pertaining to the measure of noise and light 
will be addressed via the multiple imputation (multiple 
regression) method, as a means to reduce the likelihood 
of type 1 error.
Inferential statistical procedures, including parametric 
and non-parametric statistical analyses, will be used to 
analyse any data that violates the principles for the normal 
distributions of nominal or ordinal data. Cohen’s kappa 
coefficients (κ) will be employed to determine the inter-
rater agreement between PSG and ACTG in determining 
the mutually exclusive states of wakefulness and sleep. 
The values derived from the Cohen’s kappa will be char-
acterised as follows: a result of <0 will indicate no agree-
ment, a result of 0–0.20, will indicate slight agreement, a 
result of 0.21–0.4 will indicate a fair level of agreement, 
a result of 0.61–0.80 will indicate substantial agreement 
and a result of 0.81–1 will be deemed to be an almost 
perfect agreement.69
Bland-Altman plots will be used to determine the clin-
ical comparability of PSG and ACTG and their level of 
agreement will be used to determine patients’ waking 
box 2 secondary outcome measures of the study
 ► Report the sleep architecture of intensive care patients.
 ► Compare the accuracy of polysomnography  (PSG) compared with 
actigraphy, nursing assessment and patient self-reports.
 ► Determine the accuracy of patient self-reports of sleep quality 
compared with their biophysiological data.
 ► Determine the accuracy of nurses’ observations of patients’ total 
sleep times compared with PSG.
 ► Determine the effects of noise events (>70 dB (A)) on sleep stages.
 ► Determine the effects of exposures to artificial, nocturnal light 
during the sleep stages.
 ► Identify whether any clinical interactions are causal factors that 
arouse patients’ from sleep.
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and sleep states, as a high a level of correlation does not 
necessarily indicate agreement. The computations will be 
based on a 95% limit of agreement for each comparison. 
The level of agreement between nurses’ observations 
and patients’ self-reports of sleep will also be measured 
using the Bland-Altman plot to visually present the differ-
ences in patients (x-axis) and nurses’ (y-axis) reports. The 
RCSQ scores will be classified across three domains: poor 
sleep (0–33), moderate sleep (34–66) and a good night’s 
sleep (67–100). The sleep domains of overall sleep quality 
and number of awakenings, ICU LOS, and APACHE II 
scores will be investigated via the non-parametric Spear-
man’s correlation coefficient. The Mann-Whitney test will 
be used to test the differences between groups based on 
diagnostic classifications.
The environmental data will be analysed against 
the PSG monitoring to determine the effects of noise 
events, light levels and clinical care on patients’ sleep. A 
non-parametric analysis using Spearman’s correlations 
(r) will be conducted to ascertain the effect of these envi-
ronmental factors on sleep quality. Categorical outcomes 
will be analysed using the Χ2 test or Fisher’s exact test. 
The significance level will be set at 0.05 (two tailed).
Ethics and consent
Patients admitted to the ICU for an anticipated admission 
period of 24 hours, with prehospital discharge follow-up 
for patients meeting the criteria to complete self-report 
will be identified by the ICU medical team and assessed 
by the chief investigator to determine whether they meet 
the study’s eligibility criteria. Potential participants will 
be approached and asked to provide written consent to 
participate. A patient’s severity of illness on admission may 
mean that some potential participants cannot consent. In 
such cases, the identified next of kin will be approached, 
provided information on the study and asked to provide 
or decline consent. In accordance with the relevant terri-
tory laws, patients who are under guardianship orders or 
subject to an Enduring Power of Attorney will be excluded 
from the study. In circumstances where family members 
have provided consent, once the patient is able, he/she 
will be provided with an opportunity to retrospectively 
withdraw from the study, or formally consent to partici-
pate in study.
dIssEMInAtIon
Sleep is considered an important component of recovery 
and can minimise the neurocognitive complications 
associated with sleep deprivation. Previous studies have 
revealed a number of themes that continue to go unad-
dressed in critical care environments, including iden-
tifying a method to monitor sleep, understanding the 
underlying factors that contribute to sleep disturbances 
and developing interventions that reduce the impact of 
adverse effects of sleep disturbance on patients.4 8 11 14 22 
If the challenges faced in the field are to be successfully 
overcome, research investigating sleep in the critical care 
needs to be ongoing and progressive.
This observational study will endeavour to ascertain the 
potential and ability of a motion accelerometer to accu-
rately identify ICU patients’ total sleep time and sleep 
fragmentation. Acquiring cost-effective and easily inter-
pretable data on ICU patients’ sleep and sleep distur-
bances will provide clinicians with important information 
on which they can base clinical management strategies to 
enhance patients’ overall well-being and recovery. There 
are, however, limitations associated with the study, these 
include, it being a single centre study which may limit the 
generalisability of the findings, although it may provide 
the impetus for future multicentre studies. Further, 
PSG is deemed the gold standard of sleep monitoring, 
however, its ability to monitor sleep within the intensive 
care patient cohort presents challenges in regards to the 
data acquired. The impact of missing data will be inves-
tigated as outlined and may further highlight the issues 
and complexity of sleep monitoring among ICU patients 
and the clinical feasibility of PSG monitoring. Addition-
ally, the results of this study will enhance understand-
ings of how and to what extent environmental factors 
contribute to sleep disturbance and thus provide valuable 
information that can be used to inform the future designs 
and characteristics of ICUs. The findings derived from 
this study will be submitted to academic peer-reviewed 
journals for publication and presented at relevant inter-
national and national conferences. The transfer of knowl-
edge obtained from this study will also be provided to the 
institution’s healthcare policy makers and clinicians via 
seminars and study synopses to aid in the improvement 
of clinical care.
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